Trial Profile
A Pilot Clinical Trial of Memantine for Essential Tremor.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jun 2012
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Essential tremor
- Focus Therapeutic Use
- 13 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Oct 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 02 Apr 2007 New trial record.